Cholesterol Lowering and Coronary Revascularization
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The significant reduction observed in incident coronary revascularizations, in addition to its obvious benefits on patients' health and overall quality of life, may also translate into significant reduction of expenses associated with revascularization procedures, which are a substantial component of health costs of management of patients with chronic ischaemic syndromes.35,67”
From Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis (2024) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., Edelberg, J. M., Goodman, S. G., Hanotin, C., Harrington, R. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801174 · Cited by 3,634
Nicholls, S. J., Puri, R., Anderson, T., Ballantyne, C. M., Cho, L., Kastelein, J. J. P., Koenig, W., Somaratne, R., Kassahun, H., Yang, J., et al. (2016) · JAMA · doi:10.1001/jama.2016.16951 · Cited by 1,178
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis
Nicholls, S. J., Tuzcu, E. M., Sipahi, I., Grasso, A. W., Schoenhagen, P., Hu, T., Wolski, K., Crowe, T., Desai, M. Y., Hazen, S. L., et al. (2007) · JAMA · doi:10.1001/jama.297.5.499 · Cited by 724
Di Sciascio, G., Patti, G., Pasceri, V., Gaspardone, A., Colonna, G., & Montinaro, A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.028 · Cited by 315
Research works printed but not linked: 9
- Baigent, 2010, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet, 376, 1670, 10.1016/S0140-6736(10)61350-5 · DOI · Paper page
- Nicholls, 2011, Effect of two intensive statin regimens on progression of coronary disease, N Engl J Med, 365, 2078, 10.1056/NEJMoa1110874 · DOI · Paper page
- Banerjee, 2020, Plaque Regression and Endothelial Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Circ Cardiovasc Interv, 13, 10.1161/CIRCINTERVENTIONS.119.008933 · DOI
- Oyama, 2021, Effect of evolocumab on complex coronary disease requiring revascularization, J Am Coll Cardiol, 77, 259, 10.1016/j.jacc.2020.11.011 · DOI · Paper page
- Suh, 2010, The relationship and threshold of stent length with regard to risk of stent thrombosis after drug-eluting stent implantation, J Am Coll Cardiol Intv, 3, 383, 10.1016/j.jcin.2009.10.033 · doi:10.1016/j.jcin.2009.10.033
- Mauri, 2004, Effects of stent length and lesion length on coronary restenosis, Am J Cardiol, 93, 1340, 10.1016/j.amjcard.2004.02.027 · doi:10.1016/j.amjcard.2004.02.027
- Patti, 2007, Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial, J Am Coll Cardiol, 49, 1272, 10.1016/j.jacc.2007.02.025 · DOI · Paper page
- Farkouh, 2020, Influence of LDL-cholesterol lowering on cardiovascular outcomes in patients with diabetes mellitus undergoing coronary revascularization, J Am Coll Cardiol, 76, 2197, 10.1016/j.jacc.2020.09.536 · DOI
- Koskinas, 2019, Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS), J Am Coll Cardiol, 74, 2452, 10.1016/j.jacc.2019.08.010 · DOI · Paper page
Cited by
Dinu, M., Sofi, F., Lotti, S., Colombini, B., Mattioli, A. V., Catapano, A. L., Casula, M., Baragetti, A., Wong, N. D., Steg, P. G., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae184 · Cited by 43
Metadata
- Authors
- Ohman, E. M., & Nanna, M. G.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 77
- Issue
- 3
- Pages
- 268-270
- ISSN
- 0735-1097
- Cited by
- 1
- References
- 5
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 390 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cholesterol Lowering and Coronary Revascularization. https://app.cochat.ai/papers/10.1016/j.jacc.2020.11.036
- The paper
- Ohman, E. M., & Nanna, M. G. (2021). Cholesterol Lowering and Coronary Revascularization. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2020.11.036
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.